Literature DB >> 8395024

Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes.

J Rothe1, W Lesslauer, H Lötscher, Y Lang, P Koebel, F Köntgen, A Althage, R Zinkernagel, M Steinmetz, H Bluethmann.   

Abstract

Tumour necrosis factor (TNF), jointly referring to TNF alpha and TNF beta, is a central mediator of immune and inflammatory responses; its activities are mediated by two distinct receptors, TNFR1 (p55) and TNFR2 (p75) (reviewed in refs 1-3). The cytoplasmic domains of the TNFRs are unrelated, suggesting that they link to different intracellular signalling pathways. Although most TNF responses have been assigned to one or the other of the TNF receptors (mostly TNFR1), there is no generally accepted model for the physiological role of the two receptor types. To investigate the role of TNFR1 in beneficial and detrimental activities of TNF, we generated TNFR1-deficient mice by gene targeting. We report here that mice homozygous for a disrupted Tnfr1 allele (Tnfr1(0)) are resistant to the lethal effect of low doses of lipopolysaccharide after sensitization with D-galactosamine, but remain sensitive to high doses of lipopolysaccharide. The increased susceptibility of Tnfr1(0)/Tnfr1(0) mutant mice to infection with the facultative intracellular bacterium Listeria monocytogenes indicates an essential role of TNF in nonspecific immunity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395024     DOI: 10.1038/364798a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  336 in total

Review 1.  Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis.

Authors:  C L Verweij
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  New insights into the biology of the acute phase response.

Authors:  A F Suffredini; G Fantuzzi; R Badolato; J J Oppenheim; N P O'Grady
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

Review 3.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

4.  Impairment of TNF-receptor-1 signaling but not fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice.

Authors:  R Bachmann; H P Eugster; K Frei; A Fontana; H Lassmann
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

5.  Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome.

Authors:  Anna Simon; Heiyoung Park; Ravikanth Maddipati; Adrian A Lobito; Ariel C Bulua; Adrianna J Jackson; Jae Jin Chae; Rachel Ettinger; Heleen D de Koning; Anthony C Cruz; Daniel L Kastner; Hirsh Komarow; Richard M Siegel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

6.  The 75-kD tumour necrosis factor (TNF) receptor is specifically up-regulated in monocytes during Q fever endocarditis.

Authors:  E Ghigo; C Capo; N Amirayan; D Raoult; J Mege
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

7.  Mice lacking the TNF 55 kDa receptor fail to sleep more after TNFalpha treatment.

Authors:  J Fang; Y Wang; J M Krueger
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

8.  Characterization of tumor necrosis factor-deficient mice.

Authors:  M W Marino; A Dunn; D Grail; M Inglese; Y Noguchi; E Richards; A Jungbluth; H Wada; M Moore; B Williamson; S Basu; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

9.  Deficiency in tumor necrosis factor alpha activity does not impair early protective Th1 responses against blood-stage malaria.

Authors:  H Sam; Z Su; M M Stevenson
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

10.  TNF-α type 2 receptor mediates renal inflammatory response to chronic angiotensin II administration with high salt intake in mice.

Authors:  Purnima Singh; Laleh Bahrami; Alexander Castillo; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.